MSH2 and colorectal cancer: At the same time, Ligtenberg et al. (2009) detected similar EPCAM 3′ end deletions in four Dutch families with colorectal cancer, showing high microsatellite instability and loss of the MSH2 protein, but in which no mutations in MSH2 were found.